Day: March 22, 2022

Financial results and business update call scheduled for 5:00 PM ET today LOUISVILLE, Colo., March 22, 2022 (GLOBE NEWSWIRE) — Solid Power, Inc. (Nasdaq: SLDP), an industry-leading developer of all-solid-state battery cells for electric vehicles, today announced its financial results for the full year ended December 31, 2021. Recent business highlights:The completion of Solid Power’s business combination on December 8, 2021, resulting in net cash proceeds of $495 million to fund its product development and strategic growth plans Completion of all planned 2021 milestones, including the start of production of 20 Ah high-content silicon anode cells (“Silicon EV Cells”) on the Company’s pilot production line Partnership with leading lithium-ion cell producer SK Innovation Co., Ltd. to validate that Solid Power’s all-solid-state cell...

Highlights of the fiscal year include:Revenue of $756.6 million, an increase of 3% compared to $733.6 million in FY21. Net loss of $44.3 million, compared to net income of $8.8 million in FY21, with non-GAAP net income of $110.2 million, compared to $127.6 million in FY21. Net loss per diluted share of $0.53, compared to net income per diluted share of $0.12 in FY21, with non-GAAP net income per diluted share of $1.33, compared to $1.69 in FY21. Adjusted EBITDA of $236.0 million, a decrease of 2% compared to $240.8 million in FY21. 7.2 million HSAs, an increase of 25% compared to FY21. Total HSA Assets of $19.6 billion, an increase of 37% compared to FY21. 14.4 million Total Accounts, including both HSAs and complementary CDBs, an increase of 12% compared to FY21. The Company sold 5,750,000 shares of common stock, yielding net proceeds...

Q4 Gross Merchandise Value Increased 27% Year-over-Year to $490.8 millionQ4 Total Revenue Increased 22% Year-over-Year to $84.2 millionQ4 Adjusted EBITDA was ($4.7) million with (5.5%) margins REDWOOD CITY, Calif., March 22, 2022 (GLOBE NEWSWIRE) — Poshmark, Inc. (NASDAQ: POSH), a leading social marketplace for new and secondhand style, today announced financial results for its fourth quarter and full year ended December 31, 2021. The Company posted net revenues of $84.2 million in the fourth quarter of 2021, which is a 22% year-over-year increase from the fourth quarter of 2020. Gross Merchandise Value (“GMV”) grew 27% year-over-year from the fourth quarter of 2020 to $490.8 million, up from $387.2 million. “We had a strong finish to a historic year for Poshmark with record GMV and revenues. Despite a very unpredictable and volatile...

– HM43239 clinical remission at 120mg expands list of potential treatable AML populations – – On track to initiate genotype-enriched expansion program for HM43239 in 2H22 – – Cash runway into fourth quarter of 2023 – – Conference call and webcast at 5:00 pm ET today – SAN DIEGO and TORONTO, March 22, 2022 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral kinase inhibitors to treat hematologic malignancies, today announced financial results for the three months and year ended December 31, 2021 and provided a corporate update. The net loss for the quarter ended December 31, 2021 was $24.3 million ($0.27 per share) compared with $14.7 million ($0.17 per share)...